A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for th
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for th
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement
Status
Status :
Completed
Type of study
Phase IV
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Dermatology
Disease :
Onychomycosis
Study medication :
Rv4104a (Onyster)
Phase :
Phase IV
Start Date :
10 November 2008
End date :
29 August 2011
Study ID :
RV4104A 2008 548
EudraCT/CTIS number :
2009-011125-14
Send by email